Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 1

Status

Terminated 2Unknown 1

Sponsor Class

OTHER 3INDUSTRY 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 297Lymphoid 245Other hematologic neoplasm 116Myeloid 18Genitourinary 13Gastrointestinal 10Dermatologic 10CNS 7Sarcoma 5Tumor-Agnostic 4Other solid neoplasm 4Classical hematology 4Thoracic 3Gynecologic 3Head & Neck 2Breast 2NET 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Recurrence 1Head and Neck Neoplasms 1Colorectal Neoplasms 1

Interventions

Carboplatin 508Cisplatin 410Pemetrexed 399Radiotherapy 282Docetaxel 244Paclitaxel 227pembrolizumab 225Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 176Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Vinorelbine 90Magnetic Resonance Spectroscopy 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Lenalidomide × Thoracic × Clear all
NCT02963610 2021-12-30

Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer

Fox Chase Cancer Center

Phase 1/2 Terminated
3 enrolled 5 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT02018523 2018-01-18

Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer

Baylor College of Medicine

Phase 1 Terminated
7 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01166035 2010-07-20

TEXO

Medical University Innsbruck

Phase 1/2 Unknown
20 enrolled
GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡